The aim of this work was to determine the effects of different time of
tobacco smoke exposure on pharmacokinetics of bupivacaine in mice. Mi
ce were exposed to tobacco smoke during 4 days (group T4) or 8 days (g
roup T8) using the Hamburg II smoking machine. Controls were exposed u
nder the same experimental conditions but without tobacco smoke. Serum
pharmacokinetic parameters, protein or erythrocyte binding of bupivac
aine were measured on the 4th and 8th day of exposure. Furthermore the
urines were kept during 24 hours and urine metabolite percentages wer
e determined. After the short exposure (4 days), no differences betwee
n treated and control groups were reported in contrary to the longer e
xposure (8 days), where data showed a significantly increased metaboli
sm and elimination of bupivacaine in the treated group compared to the
controls. Our data indicate that tobacco smoke acts at different leve
ls i.e. metabolism, elimination and binding of bupivacaine. Tobacco sm
oke exposure increases the metabolism of bupivacaine by activating the
hydroxylation route and by inducing an important elimination of 3OH-b
upivacaine. Besides, it increases the permeability of the cell membran
es and facilitates the penetration of bupivacaine and desbutylbupivaca
ine in erythrocytes.